Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fizzotti

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Blood|November 24, 1999
Lymphomas expressing ALK fusion protein(s) other than NPM-ALKB Falini, K Pulford, A Pucciarini, et al.
Blood|January 15, 1996
Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's diseaseB Falini, B Bigerna, L Pasqualucci, et al.
The American Journal of Pathology|May 1, 1996
Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal regionL Flenghi, B Bigerna, M Fizzotti, et al.
The American Journal of Pathology|September 15, 1998
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrumB Falini, B Bigerna, M Fizzotti, et al.
Blood|April 9, 1999
ALK+ lymphoma: clinico-pathological findings and outcomeB Falini, S Pileri, P L Zinzani, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Blood|November 24, 1999
Lymphomas expressing ALK fusion protein(s) other than NPM-ALKB Falini, K Pulford, A Pucciarini, et al.
Blood|January 15, 1996
Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's diseaseB Falini, B Bigerna, L Pasqualucci, et al.
The American Journal of Pathology|May 1, 1996
Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal regionL Flenghi, B Bigerna, M Fizzotti, et al.
The American Journal of Pathology|September 15, 1998
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrumB Falini, B Bigerna, M Fizzotti, et al.
Blood|April 9, 1999
ALK+ lymphoma: clinico-pathological findings and outcomeB Falini, S Pileri, P L Zinzani, et al.
Pageof 4